{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:22:37Z","timestamp":1779200557397,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1187-7","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T08:35:10Z","timestamp":1543826110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer"],"prefix":"10.1186","volume":"13","author":[{"given":"Hendrik","family":"Dapper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"M\u00fcnch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Peeken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Borm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Habermehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,3]]},"reference":[{"key":"1187_CR1","volume-title":"Langversion 2.0 - November 2017 - AWMF-Registernummer: 021\/007OL","author":"S3-Leitlinie kolorektales Karzinom","year":"2017","unstructured":"S3-Leitlinie kolorektales Karzinom. Langversion 2.0 - November 2017 - AWMF-Registernummer: 021\/007OL. Stuttgart: Thieme; 2017."},{"key":"1187_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","volume":"246","author":"KC Peeters","year":"2007","unstructured":"Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246:693\u2013701.","journal-title":"Ann Surg"},{"key":"1187_CR3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/archsurg.133.8.894","volume":"133","author":"RJ Heald","year":"1998","unstructured":"Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133:894\u20139.","journal-title":"Arch Surg"},{"key":"1187_CR4","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3748\/wjg.v17.i13.1674","volume":"17","author":"JM Enr\u00edquez-Navascu\u00e9s","year":"2011","unstructured":"Enr\u00edquez-Navascu\u00e9s JM, Borda N, Lizerazu A, et al. Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol. 2011;17:1674\u201384.","journal-title":"World J Gastroenterol"},{"key":"1187_CR5","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","volume":"30","author":"R Sauer","year":"2012","unstructured":"Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30:1926\u201333.","journal-title":"J Clin Oncol"},{"key":"1187_CR6","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jama.284.8.1008","volume":"284","author":"C Camm\u00e0","year":"2000","unstructured":"Camm\u00e0 C, Giunta M, Fiorica F, Pagliaro L, Crax\u00ec A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA. 2000;284:1008\u201315.","journal-title":"JAMA"},{"key":"1187_CR7","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731\u201340.","journal-title":"N Engl J Med"},{"key":"1187_CR8","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","volume":"27","author":"MS Roh","year":"2009","unstructured":"Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009;27:5124\u201330.","journal-title":"J Clin Oncol"},{"key":"1187_CR9","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1200\/JCO.2004.08.170","volume":"22","author":"J-P Gerard","year":"2004","unstructured":"Gerard J-P, Chapet O, Nemoz C, et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomized trial. J Clin Oncol. 2004;22:2404\u20139.","journal-title":"J Clin Oncol"},{"key":"1187_CR10","doi-asserted-by":"publisher","first-page":"e4638","DOI":"10.1097\/MD.0000000000004638","volume":"95","author":"C-H Chen","year":"2016","unstructured":"Chen C-H, Wei P-L, Hsieh M-C, et al. The outcomes of therapeutic decision in lower 3rd rectal cancer patients. Medicine (Baltimore). 2016;95:e4638.","journal-title":"Medicine (Baltimore)"},{"key":"1187_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0360-3016(98)00180-1","volume":"42","author":"R Wagman","year":"1998","unstructured":"Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty PP. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys. 1998;42:51\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1187_CR12","unstructured":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe (Leitlinienprogramm Onkologie). Interdisziplin\u00e4re Leitlinie der Qualit\u00e4t S3 zur Fr\u00fcherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Langversion 5.0 AWMF); 2018. \n                    http:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/prostatakarzinom\/\n                    \n                   [accessed last checked: November 3, 2018]."},{"key":"1187_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.6004\/jnccn.2010.0007","volume":"8","author":"PF Engstrom","year":"2010","unstructured":"Engstrom PF, Arnoletti JP, Benson AB, et al. NCCN clinical practice guidelines in oncology. Anal carcinoma J Natl Compr Canc Netw. 2010;8:106\u201320.","journal-title":"Anal carcinoma J Natl Compr Canc Netw"},{"key":"1187_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ygyno.2011.12.432","volume":"125","author":"D X-l","year":"2012","unstructured":"X-l D, Tao J, X-g S, et al. Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy. Gynecol Oncol. 2012;125:151\u20137.","journal-title":"Gynecol Oncol"},{"key":"1187_CR15","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/cncr.29983","volume":"122","author":"GA Viani","year":"2016","unstructured":"Viani GA, Viana BS, Martin JEC, Rossi BT, Zuliani G, Stefano EJ. Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: a randomized clinical trial. Cancer. 2016;122:2004\u201311.","journal-title":"Cancer"},{"key":"1187_CR16","doi-asserted-by":"publisher","first-page":"e0183339","DOI":"10.1371\/journal.pone.0183339","volume":"12","author":"Y-K Kwak","year":"2017","unstructured":"Kwak Y-K, Lee S-W, Kay CS, Park HH. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose. PLoS One. 2017;12:e0183339.","journal-title":"PLoS One"},{"key":"1187_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1748-717X-5-17","volume":"5","author":"L Arbea","year":"2010","unstructured":"Arbea L, Ramos LI, Mart\u00ednez-Monge R, Moreno M, Aristu J. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol. 2010;5:17.","journal-title":"Radiat Oncol"},{"key":"1187_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13014-017-0894-9","volume":"12","author":"H Yamashita","year":"2017","unstructured":"Yamashita H, Ishihara S, Nozawa H, et al. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy\/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis. Radiat Oncol. 2017;12:156.","journal-title":"Radiat Oncol"},{"key":"1187_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/jrr\/rrw087","volume":"58","author":"C-M Huang","year":"2017","unstructured":"Huang C-M, Huang M-Y, Tsai H-L, et al. A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma. J Radiat Res. 2017;58:247\u201359.","journal-title":"J Radiat Res"},{"key":"1187_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2147\/CMAR.S142076","volume":"10","author":"DK Simson","year":"2018","unstructured":"Simson DK, Mitra S, Ahlawat P, et al. Prospective study of neoadjuvant chemoradiotherapy using intensity-modulated radiotherapy and 5 fluorouracil for locally advanced rectal cancer - toxicities and response assessment. Cancer Manag Res. 2018;10:519\u201326.","journal-title":"Cancer Manag Res"},{"key":"1187_CR21","doi-asserted-by":"publisher","first-page":"874","DOI":"10.6004\/jnccn.2018.0061","volume":"16","author":"AB Benson","year":"2018","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al. Rectal Cancer, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16:874\u2013901.","journal-title":"J Natl Compr Cancer Netw"},{"key":"1187_CR22","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1080\/02841860802195251","volume":"47","author":"KJ Emmertsen","year":"2008","unstructured":"Emmertsen KJ, Laurberg S. Bowel dysfunction after treatment for rectal cancer. Acta Oncol. 2008;47:994\u20131003.","journal-title":"Acta Oncol"},{"key":"1187_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0140-6736(05)63141-8","volume":"350","author":"L Lundby","year":"1997","unstructured":"Lundby L, Jensen VJ, Overgaard J, Laurberg S. Long-term colorectal function after postoperative radiotherapy for colorectal cancer. Lancet. 1997;350:564.","journal-title":"Lancet"},{"key":"1187_CR24","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/bjs.5525","volume":"93","author":"J Pollack","year":"2006","unstructured":"Pollack J, Holm T, Cedermark B, et al. Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg. 2006;93:1519\u201325.","journal-title":"Br J Surg"},{"key":"1187_CR25","doi-asserted-by":"publisher","first-page":"8697","DOI":"10.1200\/JCO.2005.02.9017","volume":"23","author":"H Birgisson","year":"2005","unstructured":"Birgisson H, P\u00e5hlman L, Gunnarsson U, Glimelius B. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish rectal Cancer trial. J Clin Oncol. 2005;23:8697\u2013705.","journal-title":"J Clin Oncol"},{"key":"1187_CR26","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","volume":"23","author":"KCMJ Peeters","year":"2005","unstructured":"Peeters KCMJ, van de Velde CJH, Leer JWH, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. J Clin Oncol. 2005;23:6199\u2013206.","journal-title":"J Clin Oncol"},{"key":"1187_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/archsurg.138.3.257","volume":"138","author":"K Ammann","year":"2003","unstructured":"Ammann K, Kirchmayr W, Klaus A, et al. Impact of neoadjuvant chemoradiation on anal sphincter function in patients with carcinoma of the midrectum and low rectum. Arch Surg. 2003;138:257\u201361.","journal-title":"Arch Surg"},{"key":"1187_CR28","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/j.ijrobp.2012.03.065","volume":"84","author":"D Alsadius","year":"2012","unstructured":"Alsadius D, Hedelin M, Lundstedt D, Pettersson N, Wilder\u00e4ng U, Steineck G. Mean absorbed dose to the anal-sphincter region and fecal leakage among irradiated prostate cancer survivors. Int J Radiat Oncol Biol Phys. 2012;84:e181\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1187_CR29","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s12094-017-1627-0","volume":"19","author":"F Arias","year":"2017","unstructured":"Arias F, Eito C, As\u00edn G, et al. Fecal incontinence and radiation dose on anal sphincter in patients with locally advanced rectal cancer (LARC) treated with preoperative chemoradiotherapy: a retrospective, single-institutional study. Clin Transl Oncol. 2017;19:969\u201375.","journal-title":"Clin Transl Oncol"},{"key":"1187_CR30","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1200\/JCO.2014.58.5828","volume":"33","author":"D Wang","year":"2015","unstructured":"Wang D, Zhang Q, Eisenberg BL, et al. Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: results of radiation therapy oncology group RTOG-0630 trial. J Clin Oncol. 2015;33:2231\u20138.","journal-title":"J Clin Oncol"},{"key":"1187_CR31","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76:S10\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1187_CR32","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"RJ Myerson","year":"2009","unstructured":"Myerson RJ, Garofalo MC, El Naqa I, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009;74:824\u201330.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1187_CR33","first-page":"578243","volume":"2014","author":"Y-J Chen","year":"2014","unstructured":"Chen Y-J, Chen MB, Liu AJ, Sanchez J, Tsai P, Liu A. Dosimetric coverage of the external anal sphincter by 3-dimensional conformal fields in rectal cancer patients receiving neoadjuvant chemoradiation: implications for the concept of sphincter-preserving radiation therapy. Biomed Res Int. 2014;2014:578243.","journal-title":"Biomed Res Int"},{"key":"1187_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.radonc.2012.03.002","volume":"103","author":"F Buettner","year":"2012","unstructured":"Buettner F, Gulliford SL, Webb S, Sydes MR, Dearnaley DP, Partridge M. The dose-response of the anal sphincter region--an analysis of data from the MRC RT01 trial. Radiother Oncol. 2012;103:347\u201352.","journal-title":"Radiother Oncol"},{"key":"1187_CR35","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ijrobp.2009.11.012","volume":"79","author":"CD Fuller","year":"2011","unstructured":"Fuller CD, Nijkamp J, Duppen JC, et al. Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting. Int J Radiat Oncol Biol Phys. 2011;79:481\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1187_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.radonc.2011.08.011","volume":"102","author":"J Nijkamp","year":"2012","unstructured":"Nijkamp J, de Haas-Kock DF, Beukema JC, et al. Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands. Radiother Oncol. 2012;102:14\u201321.","journal-title":"Radiother Oncol"},{"key":"1187_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.radonc.2016.06.005","volume":"120","author":"I Joye","year":"2016","unstructured":"Joye I, Macq G, Vaes E, et al. Do refined consensus guidelines improve the uniformity of clinical target volume delineation for rectal cancer? Results of a national review project. Radiother Oncol. 2016;120:202\u20136.","journal-title":"Radiother Oncol"},{"key":"1187_CR38","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ijrobp.2008.01.063","volume":"72","author":"E Syk","year":"2008","unstructured":"Syk E, Torkzad MR, Blomqvist L, Nilsson PJ, Glimelius B. Local recurrence in rectal cancer: anatomic localization and effect on radiation target. Int J Radiat Oncol Biol Phys. 2008;72:658\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1187_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ejso.2009.11.011","volume":"36","author":"M Kusters","year":"2010","unstructured":"Kusters M, Marijnen CAM, van de Velde CJH, et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010;36:470\u20136.","journal-title":"Eur J Surg Oncol"},{"key":"1187_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.radonc.2016.07.017","volume":"120","author":"V Valentini","year":"2016","unstructured":"Valentini V, Gambacorta MA, Barbaro B, et al. International consensus guidelines on clinical target volume delineation in rectal cancer. Radiother Oncol. 2016;120:195\u2013201.","journal-title":"Radiother Oncol"},{"key":"1187_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.adro.2017.04.001","volume":"2","author":"JR Gunther","year":"2017","unstructured":"Gunther JR, Chadha AS, Shin US, et al. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: a matched-pair analysis. Adv Radiat Oncol. 2017;2:455\u201364.","journal-title":"Adv Radiat Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1187-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1187-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1187-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:08:54Z","timestamp":1575331734000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1187-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1187"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1187-7","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"29 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the ethics standards at the Technical University of Munich (TUM) (ethical vote: 21.06.2018, 266\/18\u2009S).Name of committee: Ethikkommission der Technischen Universit\u00e4t M\u00fcnchen.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"237"}}